Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immune response to meningococci].

T Flaegstad

    Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
    |January 10, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Neisseria meningitidis causes deadly epidemics. A new vaccine is needed because the common Serogroup B vaccine provides poor protection against this prevalent bacterium.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Colonisation and interaction between S. epidermidis and S. aureus in the nose and throat of healthy adolescents.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
    Same author

    Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.

    British journal of cancer·2011
    Same author

    Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2007
    Same author

    Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation.

    Pediatric blood & cancer·2004
    Same author

    Rapid PCR detection of the methicillin resistance gene, mecA, on the hands of medical and non-medical personnel and healthy children and on surfaces in a neonatal intensive care unit.

    Scandinavian journal of infectious diseases·2001
    Same author

    Rapid detection of the methicillin-resistance gene, mecA, in coagulase-negative Staphylococci.

    Scandinavian journal of infectious diseases·2001

    Area of Science:

    • Microbiology
    • Immunology
    • Epidemiology

    Background:

    • Neisseria meningitidis is a significant cause of bacterial meningitis and sepsis.
    • Meningococcal disease outbreaks pose a substantial public health threat, particularly in certain regions.
    • Current understanding of the bacterium's immunological aspects is crucial for effective control strategies.

    Purpose of the Study:

    • To review the immunological factors involved in Neisseria meningitidis colonization and invasion.
    • To evaluate the efficacy of existing vaccines against prevalent meningococcal serogroups.
    • To highlight the need for specialized vaccines against specific serogroups, such as Serogroup B in Norway.

    Main Methods:

    • Literature review of immunological responses to Neisseria meningitidis.

    Related Experiment Videos

  • Analysis of vaccine effectiveness data for different meningococcal serogroups.
  • Epidemiological data review focusing on prevalent serogroups in specific geographic areas.

    • Main Results:

    • Serogroup B polysaccharide has demonstrated a limited or absent immunological response in individuals.
    • This lack of response necessitates alternative vaccine approaches for effective protection.
    • Neisseria meningitidis remains a significant challenge due to varying serogroup prevalence and vaccine efficacy.

    Conclusions:

    • The immunological response to Serogroup B polysaccharide is insufficient for protective immunity.
    • Development of a specialized vaccine is critical to address the high mortality associated with prevalent meningococcal serogroups.
    • Targeted vaccination strategies are essential for controlling Neisseria meningitidis epidemics, particularly in Norway.